Instituto de Oftalmología Fundación Conde de Valenciana

institutodeoftalmologia.org

Total trials

41

Active

13

Phase 3

2

Total enrollment

3,087

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 6 of 6 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
topical hyaluronic acid, ascorbic acid, and sodium DNA following ablative fractional laser treatment1
Intralesional administration of 5-fluorouracil1
Nepafenac and lubricant1
Silicone-based topical formulation with sunscreen (SPF 50) application1
insulin lispro1
Ophthalmic administration of tropicamide/phenylephrine 8 mg/50 mg/mL.1

Next readouts

  • 2025-06-01
  • 2026-02-28
  • 2026-03-02
  • 2026-03-31
  • 2026-05-31
  • 2026-09

Top conditions

  • Keratoconus4
  • Dry Eye3
  • Pterygium3
  • Conjunctivitis, Allergic2
  • Pterygium of Both Eyes2
  • Recurrent Pterygium2
  • Sjogren Syndrome1
  • Skin Quality Improvement1

Frequently asked questions about Instituto de Oftalmología Fundación Conde de Valenciana

How many clinical trials does Instituto de Oftalmología Fundación Conde de Valenciana have on ClinicalTrials.gov?
Instituto de Oftalmología Fundación Conde de Valenciana is listed as the lead sponsor on 41 clinical trials in ClinicalTrials.gov, 13 of which are currently active (recruiting, enrolling, or ongoing).
How many of Instituto de Oftalmología Fundación Conde de Valenciana's trials are in Phase 3?
2 of Instituto de Oftalmología Fundación Conde de Valenciana's trials are in Phase 3, spread across 6 active drug programs.
What therapeutic areas does Instituto de Oftalmología Fundación Conde de Valenciana focus on?
Instituto de Oftalmología Fundación Conde de Valenciana's most-studied conditions on ClinicalTrials.gov are Keratoconus, Dry Eye, Pterygium, Conjunctivitis, Allergic, Pterygium of Both Eyes.
When are Instituto de Oftalmología Fundación Conde de Valenciana's next clinical trial readouts?
Instituto de Oftalmología Fundación Conde de Valenciana has 6 upcoming primary-completion readouts tracked here; the soonest is “Comparing Efficacy of Autologous Serum Eye Drops With and Without Insulin in Autoimmune Dry Eye: A Randomized Clinical Trial”, expected around 2025-06-01.